Ocean Biomedical, Inc. Intellectual Property Contracts & Agreements
18 Contracts & Agreements
- License Agreements (18 contracts)
- Third Amendment to Exclusive License Agreement (PfGARP/PfSEA) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (Chit1) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (FRGxPD-1) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (Anti-CTLA4) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Third Amendment to Exclusive License Agreement (FRG) by and between the Registrant and Elkurt, Inc., dated as of March 25, 2022 (Filed With SEC on April 11, 2022)
- Amended and Restated Exclusive License Agreement, dated as of February 25, 2021, by and between the Registrant and Teton Therapeutics Inc (Filed With SEC on February 4, 2022)
- Amended and Restated Nonexclusive License Agreement for COVID-19 Related Technology, dated as of March 3, 2021 by and between the Registrant and The Board of Trustees of the... (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (PfGARP/PfSEA) by and between the Registrant and Elkurt Inc., dated as of September 10, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (Chit1) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (FRGxPD-1) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (Anti-CTLA4) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Second Amendment to Exclusive License Agreement (FRG) by and between the Registrant and Elkurt Inc., dated as of August 31, 2021 (Filed With SEC on February 4, 2022)
- Exclusive License Agreement (PfGARP/PfSEA), dated as of January 25, 2021, by and between the Registrant and Elkurt Inc., as amended on April 1, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (Chit1), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (FRGxPD-1), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (Anti-CTLA4), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Exclusive License Agreement (FRG), dated as of July 31, 2020, by and between the Registrant and Elkurt Inc., as amended on March 21, 2021 (Filed With SEC on June 22, 2021)
- Nonexclusive License Agreement for COVID-19 Related Technology, dated as of June 25, 2020, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior... (Filed With SEC on June 9, 2021)
